Follow Healthline   |   Healthline on TwitterTwitter   |   Healthline on FacebookFacebook
Symptom Search   |   Treatment Search   |   Doctor Search   |   Drug Search

Hepatitis C : News

Advertisement
Marketplace
... Khalid Iqbal Malik while talking to 'The News'. The PCR equipment is used for diagnostic purpose in diseases like hepatitis B & C and tuberculosis. It is for the first time that the government authorities are going to provide the PCR testing ...
Source:The News
Date:October 2, 2009
... percent, in after-hours trading. It's the second disappointment for SciClone in the past 12 months. A late-stage hepatitis C trial with Zadaxin, also known as thymalfasin, failed last November, though SciClone is looking for a partner for a Phase ...
Source:East Bay Business Times
Date:October 2, 2009
One of the most common reasons for needing a liver transplant is liver failure or liver cancer caused by liver cell infection with hepatitis C virus .
Source:RedOrbit
Date:October 2, 2009
A study by the New Mexico Department of Health shows there are high rates of hepatitis C infection among long-haul truck drivers, and many of them are not aware they have the disease.
Source:Alamogordo Daily News
Date:October 2, 2009
... of heroin and other opiate addictions; 2 they save many, many lives by preventing opiate overdoses, AIDS, hepatitis C and B, black-market-related violence, etc.; 3 they are meant to be taken under the tongue, not intravenously; 4 drug use and abuse ...
Source:Santa Cruz Sentinel
Date:October 2, 2009
A healthcare worker draws blood from a young boy to test for the virus hepatitis C at a clinic in Cairo.
Source:TheNational
Date:October 1, 2009
Shares of Vertex Pharmaceuticals Inc. fell yesterday after the company forecast a wider 2009 loss while raising $155 million through new debt and the sale of milestone payment rights for the hepatitis C drug candidate telaprevir.
Source:The Boston Globe
Date:October 1, 2009
Hepatitis C virus is one of the main causes of liver-related morbidity and mortality.
Source:Virology Journal
Date:October 1, 2009
Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that two abstracts on IDX184, the company's lead hepatitis C development program, have been accepted for presentation at the 60th Annual Meeting of the American Association for the ...
Source:Small Times
Date:October 1, 2009
By Liz Highleyman Interferon-based therapy for hepatitis C has several well-known side effects, including depression and blood cell deficiencies .
Source:HIV and Hepatitis
Date:October 1, 2009
IL28B is associated with response to chronic hepatitis C interferon- and ribavirin therapy Hepatitis C virus infects 3% of the world's population.
Source:Nature Publishing Group
Date:September 13, 2009
People infected with hepatitis C virus have an increased risk of developing type 2, or "adult-onset" diabetes, a population-based study confirms.
Source:Canada.com
Date:July 25, 2007
Advertisement
Back to Top